Zonova

Around one in ten patients develop an infection during their stay in hospital, and 70% of those are linked to medical devices like catheters, IV lines, and breathing tubes. Bacteria stick to these plastics, form biofilms, and can lead to serious complications such as sepsis, pneumonia, or urinary tract infections. This is a challenge seen not only in human hospitals, but also across veterinary care - showing the urgent need for solutions that work across both human and animal health.

Zonova's patented technology changes that. It's built directly into everyday medical plastics, enabling them to kill bacteria on contact and help stop infections at the source. Rather than manufacturing, Zonova takes a licensing-first approach, partnering with global device companies to bring its innovation to market faster and at scale. With three patents filed, pilots starting, and interest from multiple multi billion-pound partners, Zonova is redefining infection prevention - driving a global shift from treatment to protection.

A link to your website https://zonovatech.com/